What is the recommended approach to managing a chronic condition, such as diabetes or hypertension, in an adult patient, in line with the Choose Wisely campaign?

Managing Chronic Conditions in Line with Choose Wisely Principles

For adults with diabetes and hypertension, implement team-based care with structured protocols targeting blood pressure <140/90 mmHg using ACE inhibitors or ARBs as first-line agents, HbA1c <7.5-8.0% using metformin initially, while avoiding routine unnecessary testing and prioritizing lifestyle interventions before medication intensification. 1, 2

Core Choose Wisely Principles Applied to Chronic Disease Management

The Choose Wisely campaign emphasizes avoiding unnecessary medical tests, treatments, and procedures through evidence-based dialogue between patients and providers. 3, 4 However, awareness-raising alone has limited effectiveness in changing clinician behavior—systematic implementation strategies are required. 3

Team-Based Care Structure (Essential Foundation)

Establish a structured team-based care model as the primary delivery system for managing diabetes and hypertension. 1

• Designate specific team members (pharmacists, nurse practitioners, nurses, medical practice coordinators) to implement medication titration algorithms under physician supervision 1
• Create protocols for timely patient contact through telephone, secure messaging, or urgent appointments 1
• Use pharmacy fill data to monitor medication adherence systematically 1
• Generate provider-specific performance reports with hypertension and diabetes metrics 1

This approach reduces systolic and diastolic blood pressure more effectively than usual care while improving appointment keeping and medication adherence. 1

Blood Pressure Management Algorithm

For patients with confirmed office BP ≥140/90 mmHg, initiate pharmacologic therapy immediately alongside lifestyle modifications. 1

Target Blood Pressure Goals:

• Standard target: <140/90 mmHg for most adults with diabetes 1
• Intensive target: 120-129 mmHg systolic if tolerated and high cardiovascular risk 1
• Geriatric patients (≥65 years): <140/90 mmHg for healthy older adults; <150/90 mmHg for those with multiple comorbidities or functional impairment 2

Critical caveat: Avoid lowering systolic BP <120 mmHg in older diabetics, as this causes harm without cardiovascular benefit and may worsen cerebral perfusion. 2, 5

First-Line Medication Selection:

• ACE inhibitors or ARBs are the preferred initial agents for patients with diabetes and hypertension, particularly with proteinuria, microalbuminuria, or left ventricular hypertrophy 1, 5
• Add thiazide-like diuretics or dihydropyridine calcium channel blockers as second-line agents 1
• For BP ≥160/100 mmHg: initiate two drugs simultaneously or use single-pill combination therapy 1

Monitoring Strategy:

• Measure BP after 5 minutes of rest, seated with feet on floor and arm supported at heart level 1
• Average at least 2 readings on at least 2 occasions 1
• Check for orthostatic hypotension before starting or intensifying therapy: measure BP after sitting/lying for 5 minutes, then at 1 and/or 3 minutes after standing 1, 2
• Use home blood pressure monitoring with platforms to communicate readings to the care team (telephonic, written, or EHR integration) 1

Glycemic Control Algorithm

Target HbA1c <7.5% for most adults with diabetes; relax to <8.0-8.5% for older adults with multiple comorbidities or limited life expectancy. 2, 5

Medication Selection Strategy:

• Metformin is the first-line agent for type 2 diabetes unless contraindicated 2, 6
• Add SGLT2 inhibitors (empagliflozin, canagliflozin, or dapagliflozin) if eGFR 30 to <90 mL/min/1.73 m² to reduce renal endpoints and cardiovascular risk 1
• Avoid sulfonylureas and meglitinides in older adults or those with functional limitations due to prolonged hypoglycemia risk 2, 5
• For patients requiring insulin, use basal insulin once daily as a reasonable option with minimal side effects 2

Patient Stratification for Geriatric Populations:

• Healthy older adults: HbA1c <7.5%, BP <140/90 mmHg 2
• Complex/intermediate health status: HbA1c <8.0%, BP <140/90 mmHg 2
• Very complex/poor health: HbA1c <8.5%, BP <150/90 mmHg 2

Critical pitfall: Aggressive glycemic control (HbA1c <7%) in older adults with multiple comorbidities increases hypoglycemia risk without proportionate benefit. 2, 5

Lifestyle Interventions (Mandatory First-Line)

Initiate lifestyle modifications for all patients with BP >120/80 mmHg or diabetes, regardless of medication status. 1

Specific Interventions:

• Weight loss if overweight or obese: target 5-7% reduction 1
• DASH dietary pattern: 8-10 servings fruits/vegetables daily, 2-3 servings low-fat dairy, sodium <2300 mg/d, increased potassium 1
• Physical activity: aerobic exercise and resistance training for all who can safely participate 1, 2
• Alcohol moderation 1
• Smoking cessation counseling as routine component of care 1

Pre-Exercise Evaluation:

• Assess for conditions contraindicating certain exercise types: uncontrolled hypertension, untreated proliferative retinopathy, autonomic neuropathy, peripheral neuropathy, history of foot ulcers 1
• Patients with diabetic autonomic neuropathy require cardiac investigation before beginning intense physical activity 1
• High-risk patients should start with short periods of low-intensity exercise, slowly increasing intensity and duration 1

Cardiovascular Risk Factor Management

Implement comprehensive cardiovascular risk reduction beyond glucose and BP control. 1

Lipid Management:

• Target LDL-C <1.4 mmol/L (<55 mg/dL) or ≥50% reduction for patients with diabetes and very high cardiovascular risk 1
• Initiate statin therapy for patients with life expectancy ≥2.5 years and ≥1 major CVD risk factor 2

Antiplatelet Therapy:

• Use aspirin for secondary prevention in patients with established cardiovascular disease 2
• Consider with caution in those ≥80 years for primary prevention 2

Screening and Monitoring Protocols

Screen annually for diabetic kidney disease by assessing eGFR and urinary albumin:creatinine ratio. 1

Avoid Unnecessary Testing:

• Do not perform routine cardiac screening in asymptomatic patients with diabetes 1
• Perform careful history and assess cardiovascular risk factors instead 1
• Reserve advanced testing for high-risk patients with atypical presentations 1

Essential Monitoring:

• Assess hypoglycemia risk at every visit, particularly in elderly patients with cognitive impairment 2, 7, 5
• Check orthostatic hypotension at each visit by measuring standing BP 2, 7, 5
• Monitor pharmacy fill data systematically for adherence 1

Patient-Centered Care Implementation

Use patient-centered communication incorporating patient preferences, literacy assessment, and cultural barriers. 1

Shared Decision-Making:

• Engage patients in determining individual BP and glycemic targets based on life expectancy, comorbidities, treatment burden, and patient attitude 1
• Involve caregivers in medication management for patients with cognitive impairment 7

Structured Education:

• Provide group-based structured education programs to improve diabetes knowledge, glycemic control, and patient empowerment 1

Common Pitfalls to Avoid

• Do not interrupt successful antihypertensive therapy when patients reach 80 years of age 5
• Avoid excessive diastolic BP lowering: maintain diastolic >70-75 mmHg in patients with coronary heart disease to prevent reduced coronary perfusion 2
• Do not use e-cigarettes as smoking cessation aids—no rigorous studies demonstrate they are healthier alternatives or facilitate cessation 1
• Regularly reassess treatment intensity and simplify complex regimens when possible to prevent overtreatment 2
• Do not rely solely on awareness-raising campaigns—implement systematic protocols with team-based accountability 3